HCPCS Level II
Q5146
Injection, trastuzumab-strf (hercessi), biosimilar, 10 mg
Codes near Q5146
These sit next to Q5146 in the CMS Level II file. All Q codes
- Q5141Injection, adalimumab-aaty, biosimilar, 1 mg
- Q5142Injection, adalimumab-ryvk biosimilar, 1 mg
- Q5143Injection, adalimumab-adbm, biosimilar, 1 mg
- Q5144Injection, adalimumab-aacf (idacio), biosimilar, 1 mg
- Q5145Injection, adalimumab-afzb (abrilada), biosimilar, 1 mg
- Q5147Injection, aflibercept-ayyh (pavblu), biosimilar, 1 mg
- Q5148Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram
- Q5149Injection, aflibercept-abzv (enzeevu), biosimilar, 1 mg
- Q5150Injection, aflibercept-mrbb (ahzantive), biosimilar, 1 mg
- Q5151Injection, eculizumab-aagh (epysqli), biosimilar, 2 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 69448-0015-05 | Hercessi | Accord BioPharma, Inc | 15 |
| 69448-0016-11 | Hercessi | Accord BioPharma, Inc | 42 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.